United States · FDA National Drug Code directory
Tazarotene
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51672-1373_4653c9f0-dc97-b1e2-e063-6294a90aaf8b
- Product NDC
- 51672-1373
- Form
- CREAM
- Composition / generic term
- Tazarotene
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170403
- Source listing expiry
- 20261231
Source-listed ingredients
- TAZAROTENE — 1 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (51672-1373-2) / 30 g in 1 TUBE · 51672-1373-2
- 1 TUBE in 1 CARTON (51672-1373-3) / 60 g in 1 TUBE · 51672-1373-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →